Biopharmaceuticals
News Release - December 20, 2010
VIVUS Files European Marketing Authorization Application for QNEXA(R) in the Treatment of Obesity
Source: VIVUS
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.